The Lancet Respiratory Medicine in conversation with
En podcast av The Lancet Group
156 Avsnitt
-
Inhaled budesonide in the treatment of early COVID-19
Publicerades: 2021-04-15 -
Tocilizumab and COVID-19
Publicerades: 2021-03-05 -
Interferon treatment and COVID-19
Publicerades: 2021-02-06 -
Evaluating deterioration in patients with acute COVID-19
Publicerades: 2021-01-12 -
Treatment options in patients with systemic sclerosis-associated interstitial lung disease
Publicerades: 2021-01-05 -
COVID-19 and severe influenza
Publicerades: 2020-12-18 -
The second wave and homeless populations
Publicerades: 2020-11-11 -
Corticosteroids, COPD, asthma and COVID-19
Publicerades: 2020-09-25 -
Novel strategies to drive down the global burden of asthma
Publicerades: 2020-09-08 -
The pathology of suspected EVALI
Publicerades: 2020-08-05 -
Wheezing illness and RSV-LRTI
Publicerades: 2020-07-17 -
Antibiotic use in infancy and asthma incidence
Publicerades: 2020-03-16 -
Guidance on the development of prediction models for critical care
Publicerades: 2020-03-12 -
Potential exacerbations in patients with COPD
Publicerades: 2020-03-03 -
CPAP and mild obstructive sleep apnea
Publicerades: 2019-11-28 -
An algorithm for EVALI
Publicerades: 2019-11-08 -
Lung transplants from Hepatitis C viremic donors
Publicerades: 2019-10-05 -
Looking to the future of cystic fibrosis care
Publicerades: 2019-09-29 -
Pamrevlumab and idiopathic pulmonary fibrosis
Publicerades: 2019-09-27 -
Nicotine patches, e-cigarettes, and smoking cessation
Publicerades: 2019-09-10
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
